Varex Imaging (VREX) Expected to Announce Quarterly Earnings on Tuesday

Varex Imaging (NASDAQ:VREX) is expected to post its Q1 2026 results after the market closes on Tuesday, February 10th. Analysts expect Varex Imaging to post earnings of $0.14 per share and revenue of $207.8250 million for the quarter. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. Individuals can find conference call details on the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Tuesday, February 10, 2026 at 5:00 PM ET.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings results on Tuesday, November 18th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.19. The business had revenue of $228.90 million during the quarter, compared to analyst estimates of $219.26 million. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%. On average, analysts expect Varex Imaging to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Varex Imaging Price Performance

NASDAQ VREX opened at $14.00 on Friday. The company has a current ratio of 3.43, a quick ratio of 1.83 and a debt-to-equity ratio of 0.75. Varex Imaging has a 1 year low of $6.76 and a 1 year high of $14.56. The company has a market cap of $586.88 million, a PE ratio of -8.24 and a beta of 0.90. The stock’s 50-day moving average price is $12.74 and its two-hundred day moving average price is $11.63.

Hedge Funds Weigh In On Varex Imaging

Several institutional investors and hedge funds have recently modified their holdings of the stock. Empowered Funds LLC increased its stake in shares of Varex Imaging by 7.3% during the 1st quarter. Empowered Funds LLC now owns 179,128 shares of the company’s stock worth $2,078,000 after purchasing an additional 12,151 shares during the last quarter. Jane Street Group LLC lifted its stake in shares of Varex Imaging by 17.9% in the 1st quarter. Jane Street Group LLC now owns 159,362 shares of the company’s stock valued at $1,849,000 after purchasing an additional 24,160 shares during the last quarter. Rhumbline Advisers boosted its holdings in Varex Imaging by 4.6% in the second quarter. Rhumbline Advisers now owns 61,820 shares of the company’s stock worth $536,000 after purchasing an additional 2,694 shares in the last quarter. Hsbc Holdings PLC increased its position in Varex Imaging by 19.7% during the second quarter. Hsbc Holdings PLC now owns 47,525 shares of the company’s stock worth $408,000 after buying an additional 7,825 shares during the last quarter. Finally, Quantbot Technologies LP increased its position in Varex Imaging by 25.1% during the second quarter. Quantbot Technologies LP now owns 47,292 shares of the company’s stock worth $410,000 after buying an additional 9,476 shares during the last quarter.

Analyst Upgrades and Downgrades

VREX has been the topic of several analyst reports. Wall Street Zen raised shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 22nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a research note on Monday, December 29th. B. Riley Financial reissued a “buy” rating and set a $16.00 target price on shares of Varex Imaging in a research note on Wednesday, November 19th. Oppenheimer reduced their target price on Varex Imaging from $23.00 to $18.00 and set an “outperform” rating for the company in a report on Wednesday, November 19th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a $14.50 target price on shares of Varex Imaging in a research report on Monday, February 2nd. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $16.17.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.